Desk›Healthcare› Sanofi Consumer Healthcare India Ltd
Sanofi Consumer Healthcare India Ltd
BSE 544250 · NSE SANOFICONR · ISIN INE0UOS01011 · Group B · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹4,213.65
+1.37%
BSE close, 28 August 2026
₹9,704.30 cr
2.3 cr shares · Small cap
₹2,769.79 cr
as published
36.5× · 35.55×
EPS ₹115.50 · BV ₹118.53
878.40 / 240.10
₹ cr, as filed
6
3 selected · 50%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -21.9% |
|---|---|
| Against 52-week low | +6.7% |
| Day change | +1.37% |
| Size band | Small cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹115.50 |
|---|---|
| Price / earnings | 36.48× |
| Price / book | 35.55× |
| Book value — derived, price ÷ P/B | ₹118.53 |
| Return on equity | 97.44% |
| Operating margin | 40.56% |
| Net margin | 29.19% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 97.45%
- ROE as published
- 97.44%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 235.70 | 68.80 | 29.87 | 40.56% | 29.19% |
| Mar-26 · Q | 229.20 | 67.80 | 29.44 | 41.19% | 29.58% |
| FY25-25 | 878.40 | 240.10 | 104.27 | 38.02% | 27.33% |
Quarter on quarter
- Revenue, quarter on quarter
- +2.8%
- Net profit, quarter on quarter
- +1.5%
- Operating margin, quarter on quarter
- -63 bps
Disclosure profile 6 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 1 |
| Press Release | 1 |
| Results | 1 |
| Selected sub-total | 3 |
| Procedural | |
| Board Meeting | 1 |
| Newspaper Publication | 1 |
| Trading Window | 1 |
| Procedural sub-total | 3 |
| Total | 6 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
6 filings · 3 selected · busiest 2026-07-28
Filing rhythm · the twelve most recent
2026-07-222026-09-28
SelectedProcedural
Filings
6 in the window · 9 earlier on record
-
28 September 2026 ·
Closure of Trading Window
Intimation for Closure of Trading Window.
Insider Trading / SAST / Closure of Trading Window View filing →
-
30 July 2026 ·
Newspaper Publication
Copy of Newspaper Publication of Unaudited Financial Results for the quarter and half year ended 30th June 2026 is enclosed.
Company Update / Newspaper Publication View filing →
-
28 July 2026 ·
Press Release / Media Release
The Board of Directors at its meeting held on Tuesday, 28th July 2026, considered and approved the Unaudited Financial Results for the quarter and half year ended 30th June 2026. In this ....
Company Update / Press Release / Media Release View filing →
-
28 July 2026 ·
Results - Financial Results For June 30, 2026
Unaudited Financial Results for the quarter and half year ended June 30, 2026 is enclosed.
Result / Financial Results View filing →
-
28 July 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday, 28Th July 2026
We wish to inform you that the Board of Directors at its meeting held today, i.e. Tuesday, 28th July 2026, inter alia considered and approved the Unaudited Financial Results for the quarter ....
Board Meeting / Outcome of Board Meeting View filing →
-
22 July 2026 ·
Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th June 2026.
Sanofi Consumer Healthcare India Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2026 ,inter alia, to consider and approve the Unaudited ....
Board Meeting / Board Meeting View filing →
RSS feed for Sanofi Consumer Healthcare India Ltd · the 50 most recent filings